# STRYKER CORP (SYK) FY2025 Q1 P&L / Income Statement

- Company: STRYKER CORP (SYK)
- Period: 2025-01-01 to 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-05-02, accession number 0000310764-25-000075
- Page: https://plicit.ai/financials/syk/fy2025-q1-income-statement
- Chart image: https://plicit.ai/charts/syk-fy2025-q1-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2025-01-01 through 2025-03-31. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,866,000,000 US dollars
- **Cost of sales**: 2,122,000,000 US dollars
- **Gross profit**: 3,744,000,000 US dollars
- **Total operating expenses**: 2,907,000,000 US dollars
- **Operating income**: 837,000,000 US dollars
- **Other income (expense), net**: negative 73,000,000 US dollars
- **Earnings before income taxes**: 764,000,000 US dollars
- **Income taxes**: 110,000,000 US dollars
- **Net earnings**: 654,000,000 US dollars
- **Other Orthopedics - Enabling Technologies**: 29,000,000 US dollars
- **Neuro Cranial - Interventional Spine**: 118,000,000 US dollars
- **Undisclosed (calculated)**: 5,719,000,000 US dollars
- **Research, development and engineering expenses**: 405,000,000 US dollars
- **Selling, general and administrative expenses**: 2,300,000,000 US dollars
- **Amortization of intangible assets**: 167,000,000 US dollars
- **Asset impairments**: 35,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/syk/fy2025-q1-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/syk-fy2025-q1-revenue-by-geography-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,866,000,000 US dollars
- **Cost of sales**: 2,122,000,000 US dollars
- **Gross profit**: 3,744,000,000 US dollars
- **Total operating expenses**: 2,907,000,000 US dollars
- **Operating income**: 837,000,000 US dollars
- **Other income (expense), net**: negative 73,000,000 US dollars
- **Earnings before income taxes**: 764,000,000 US dollars
- **Income taxes**: 110,000,000 US dollars
- **Net earnings**: 654,000,000 US dollars
- **UNITED STATES**: 4,440,000,000 US dollars
- **International**: 1,426,000,000 US dollars
- **Research, development and engineering expenses**: 405,000,000 US dollars
- **Selling, general and administrative expenses**: 2,300,000,000 US dollars
- **Amortization of intangible assets**: 167,000,000 US dollars
- **Asset impairments**: 35,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/syk/fy2025-q1-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/syk-fy2025-q1-revenue-by-business-segment-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,866,000,000 US dollars
- **Cost of sales**: 2,122,000,000 US dollars
- **Gross profit**: 3,744,000,000 US dollars
- **Total operating expenses**: 2,907,000,000 US dollars
- **Operating income**: 837,000,000 US dollars
- **Other income (expense), net**: negative 73,000,000 US dollars
- **Earnings before income taxes**: 764,000,000 US dollars
- **Income taxes**: 110,000,000 US dollars
- **Net earnings**: 654,000,000 US dollars
- **MedSurg and Neurotechnology**: 3,511,000,000 US dollars
- **Orthopaedics**: 2,355,000,000 US dollars
- **Research, development and engineering expenses**: 405,000,000 US dollars
- **Selling, general and administrative expenses**: 2,300,000,000 US dollars
- **Amortization of intangible assets**: 167,000,000 US dollars
- **Asset impairments**: 35,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment by Product and Service

- Page: https://plicit.ai/financials/syk/fy2025-q1-income-statement/revenue-by-business-segment-by-product-and-service
- Chart image: https://plicit.ai/charts/syk-fy2025-q1-revenue-by-business-segment-by-product-and-service-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,866,000,000 US dollars
- **Cost of sales**: 2,122,000,000 US dollars
- **Gross profit**: 3,744,000,000 US dollars
- **Total operating expenses**: 2,907,000,000 US dollars
- **Operating income**: 837,000,000 US dollars
- **Other income (expense), net**: negative 73,000,000 US dollars
- **Earnings before income taxes**: 764,000,000 US dollars
- **Income taxes**: 110,000,000 US dollars
- **Net earnings**: 654,000,000 US dollars
- **MedSurg and Neurotechnology - Endoscopy**: 867,000,000 US dollars
- **MedSurg and Neurotechnology - Instruments**: 730,000,000 US dollars
- **MedSurg and Neurotechnology - Medical**: 945,000,000 US dollars
- **MedSurg and Neurotechnology - Neuro Cranial**: 563,000,000 US dollars
- **MedSurg and Neurotechnology - Vascular**: 406,000,000 US dollars
- **Orthopaedics - Hips**: 443,000,000 US dollars
- **Orthopaedics - Knees**: 639,000,000 US dollars
- **Orthopaedics - Other**: 162,000,000 US dollars
- **Orthopaedics - Spinal Implants**: 166,000,000 US dollars
- **Orthopaedics - Trauma and Extremities**: 945,000,000 US dollars
- **Research, development and engineering expenses**: 405,000,000 US dollars
- **Selling, general and administrative expenses**: 2,300,000,000 US dollars
- **Amortization of intangible assets**: 167,000,000 US dollars
- **Asset impairments**: 35,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment by Geography

- Page: https://plicit.ai/financials/syk/fy2025-q1-income-statement/revenue-by-business-segment-by-geography
- Chart image: https://plicit.ai/charts/syk-fy2025-q1-revenue-by-business-segment-by-geography-sankey.png

Income statement for 2025-01-01 through 2025-03-31. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,866,000,000 US dollars
- **Cost of sales**: 2,122,000,000 US dollars
- **Gross profit**: 3,744,000,000 US dollars
- **Total operating expenses**: 2,907,000,000 US dollars
- **Operating income**: 837,000,000 US dollars
- **Other income (expense), net**: negative 73,000,000 US dollars
- **Earnings before income taxes**: 764,000,000 US dollars
- **Income taxes**: 110,000,000 US dollars
- **Net earnings**: 654,000,000 US dollars
- **MedSurg and Neurotechnology - UNITED STATES**: 2,767,000,000 US dollars
- **MedSurg and Neurotechnology - International**: 744,000,000 US dollars
- **Orthopaedics - UNITED STATES**: 1,673,000,000 US dollars
- **Orthopaedics - International**: 682,000,000 US dollars
- **Research, development and engineering expenses**: 405,000,000 US dollars
- **Selling, general and administrative expenses**: 2,300,000,000 US dollars
- **Amortization of intangible assets**: 167,000,000 US dollars
- **Asset impairments**: 35,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
